TMCnet News
It's Time To Get Onboard With Us!! Sign Up Today!! IWEB,PPHM,CODI,WHRT,LTXC,BPHX(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: IWEB) IceWEB, Inc., (NASDAQ: PPHM) Peregrine Pharmaceuticals, Inc., (NASDAQ: CODI) Compass Diversified Holdings, (NASDAQ: WHRT) World Heart Corp., (NASDAQ: LTXC) LTX-Credence Corp., (NASDAQ: BPHX) BluePhoenix Solutions Ltd. www.StockMarketingInc.com For More Information email us!! [email protected] ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: IWEB - IceWEB, Inc.) LATEST NEWS!! IceWEB Receives Multiple Data Storage Orders Company Continues to Grow Municipality Footprint STERLING, Va., April 13, 2010 -- IceWEB, Inc.(TM) (OTC Bulletin Board: IWEB), a leading provider of unified storage systems and building blocks for cloud storage networks, announced today that the Company has received multiple new customer orders from three new State and Local Government agencies. All of the awards are from first time customers and will ship in the current quarter. The IceWEB Simply Advanced(TM) line of products are a great fit for State and Local Storage administrators looking for a way to get necessary functionality at a price that is affordable. State, County and Local Governments remain understaffed and many times under Information Technology budget constraints. This creates a quandary as storage needs continue to escalate and data becomes more complex to manage. The solution however is quite simple. The IceWEB Simply Advanced storage system provides everything necessary in a unified, ready to deploy system that can scale locally and into a cloud environment. Karl Chen, IceWEB SVP of Worldwide Sales and Marketing, stated, "It is our goal to provide our channel partners with products that can scale and won't break the budget. Our digital footprint continues to grow as customers have less time to manage data and less money to do it with. Our recipe for success for our channel partners is very simple: to provide a portfolio of products that are competitive with legacy vendors like EMC and NetAPP, at a price that our customers can afford. We look forward to expanding our customer footprint through our 100% channel driven model." About IceWEB, Inc. Headquartered just outside of Washington, D.C., IceWEB manufactures and markets data storage products, network and cloud storage solutions and delivers on-line cloud computing application services. Its customer base includes U.S. government agencies, enterprise companies, and small to medium sized businesses (SMB). For more information, please visit www.IceWEB.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: PPHM - Peregrine Pharmaceuticals, Inc.) LATEST NEWS!! Peregrine Announces Data From Four Clinical Studies Will Be Presented at 2010 ASCO Annual Meeting Will Include Data From Bavituximab Breast and Non-Small Cell Lung Cancer Phase II Studies and Cotara Brain Cancer Study TUSTIN, CA, Apr 13, 2010 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical stage biopharmaceutical company developing novel monoclonal antibodies for the treatment of cancer and viral infections, today announced that data from four clinical studies of bavituximab and Cotara(R) have been accepted for presentation at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held June 4-8, 2010 in Chicago, Illinois. Abstracts Accepted at ASCO Phase II study of bavituximab plus docetaxel in locally advanced or metastatic breast cancer (Abstract #1042) Author: David Tabagari Saturday, June 5, 2:00-6:00 PM Phase II study of bavituximab plus paclitaxel and carboplatin in locally advanced or metastatic breast cancer: Interim results (Abstract #1062) Author: Minish Jain Saturday, June 5, 2:00-6:00 PM Phase II study of bavituximab plus paclitaxel and carboplatin in untreated locally advanced or metastatic non-small cell lung cancer: Interim results (Abstract #7589) Author: Raghunadharao Digumarti Sunday, June 6, 8:00 AM - 12:00 PM Open-label, dose confirmation, and dosimetry study of interstitial 131I-chTNT-1/B MAb for the treatment of recurrent glioblastoma multiforme (GBM): Final results (Abstract #2039) Author: William R. Shapiro Sunday, June 6, 8:00 AM - 12:00 PM For more information on the ASCO conference, visit http://chicago2010.asco.org/Home.aspx. About Peregrine Pharmaceuticals Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara(R). Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at www.peregrineinc.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: CODI - Compass Diversified Holdings) LATEST NEWS!! Compass Diversified Holdings Announces Pricing of 6,400,000 Share Offering WESTPORT, Conn., April 13, 2010 -- Compass Diversified Holdings (Nasdaq: CODI) announced today that it has priced a public offering of 6,400,000 trust shares at a public offering price of $15.10, representing a primary offering of 5,100,000 trust shares by CODI and a secondary offering of 1,300,000 trust shares by a selling shareholder. CODI raised approximately $73.4 million of proceeds net of underwriting discounts and commissions from its portion of the offering. The underwriters will have a 30-day option to purchase up to an additional 960,000 trust shares from CODI and the selling shareholder to cover over-allotments. CODI expects to use the net proceeds from the offering for general corporate purposes. CODI will not receive any proceeds from the secondary offering. The closing is expected to occur on or about April 16, 2010, subject to customary closing conditions. Morgan Stanley and UBS Investment Bank are the joint book-running managers on the offering, with BB&T Capital Markets, a division of Scott & Stringfellow, LLC; CJS Securities, Inc.; Janney Montgomery Scott and SunTrust Robinson Humphrey acting as co-managers. A copy of the prospectus supplement relating to the offering may be obtained from the following address: Morgan Stanley UBS Investment Bank Attn: Prospectus Dept. Attn: Prospectus Dept. 180 Varick Street, 2nd Floor 299 Park Avenue New York, NY 10014 New York, NY 10171 Email: [email protected] Telephone: 888-827-7275 Telephone: 866-718-1649 extension 3884 The offering was made pursuant to an effective shelf registration statement and prospectus filed by CODI with the SEC. You may obtain copies of the registration statement (including the base prospectus) and the final prospectus supplement for free when they are available by visiting EDGAR on the SEC web site at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering may be made only by means of a prospectus and related prospectus supplement meeting the requirements of Section 10 of the Securities Act of 1933, as amended. About Compass Diversified Holdings ("CODI") Compass Diversified Holdings ("CODI") was formed to acquire and manage a group of middle market businesses that are headquartered in North America. Its subsidiaries are a diverse group of businesses with highly defensible market positions. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: WHRT - World Heart Corp.) LATEST NEWS!! WorldHeart Announces Levacor VAD Implant at Inova Fairfax Hospital, Virginia SALT LAKE CITY, April 13, 2010 -- World Heart Corporation (Nasdaq: WHRT), a developer of mechanical circulatory systems, announced today that Inova Fairfax Hospital (Inova) in Falls Church, Virginia has successfully implanted its first Levacor(TM) Ventricular Assist Device (VAD). Inova Fairfax has extensive experience in the VAD field and is the third implanting site nationwide in the Levacor VAD Bridge-To-Transplant (BTT) Study. This is the fifth implant with the Levacor VAD since the inception of the BTT clinical study. Dr. Nelson Burton, Surgical Director of Heart Transplant and Mechanical Circulatory Support and Inova Fairfax's surgical co-Principal Investigator for the BTT clinical study commented, "We are pleased to be an active center in the Levacor BTT study. We believe that mechanical circulatory support has a significant role in the treatment of heart failure and, therefore, look forward to further advancing VAD options for our patients. " Mr. J. Alex Martin, WorldHeart's President and Chief Executive Officer added, "Inova Fairfax has consistently been recognized as one of the nation's best hospitals, specifically in the treatment of heart failure. We are enthusiastic about the study collaboration with Inova Fairfax's clinicians in the service of their patients and in the potential for expansion of VAD treatment opportunities. " About the Levacor VAD and World Heart Corporation The Levacor VAD is the only fully magnetically levitated, bearingless, implantable centrifugal pump to move into clinical trial. By using magnetic levitation to fully suspend a spinning rotor, the Levacor VAD's only moving part, the pump is designed to eliminate wear and to provide unobstructed clearances for blood flow across a wide range of operation. WorldHeart is a developer of mechanical circulatory support systems based in Salt Lake City, Utah with additional facilities in Oakland, California, USA. WorldHeart's registered office is in Delaware, USA. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: LTXC - LTX-Credence Corp.) LATEST NEWS!! LTX-Credence Announces That u-blox Has Selected the X-Series as Their Next Generation RF Test Platform u-blox Selects X-Series for Volume Production of Wireless Communications Solutions MILPITAS, Calif., Apr 13, 2010 -- LTX-Credence Corporation (Nasdaq: LTXC), a global provider of focused, cost-optimized ATE solutions, today announced that u-blox, a leading fabless semiconductor provider of embedded positioning and wireless communication solutions for the consumer, industrial and automotive markets, has selected the X-Series as their next generation RF test platform. u-blox is committed to the X-Series as its principal engineering and production test platform for all their wireless communication solutions including RF and baseband devices. Several devices have been released to volume production at u-blox's subcontract test partners in Asia. "After a thorough selection process we selected the X-Series as our next generation RF test platform because it offers excellent performance with capability to fully characterize our products while meeting our cost of test targets," said Andreas Thiel, VP R&D at u-blox. "The innovative technology of the X-Series allows us to validate the level of performance of our GPS ICs and advanced SiP modules, products with extremely low power consumption and the world's highest GPS sensitivity with an ability to lock on to weak GPS signals as low as -160 dBm thanks to u-blox's cutting-edge SuperSense(R) technology." "u-blox's commitment to the X-Series demonstrates that leading companies specializing in wireless communications technology rely on our IP to help them achieve success in the market," said Dave Tacelli, chief executive officer and president at LTX-Credence. "We are pleased that u-blox recognizes the value of the total solution we provide our customers, including innovative technology, best-in-class applications engineering, experience in testing a wide range of RF devices and a worldwide customer support team." About u-blox u-blox is a leading fabless semiconductor provider of embedded positioning and wireless communication solutions for the consumer, industrial and automotive markets. Our solutions enable people, devices, vehicles and machines to locate their exact position and wirelessly communicate via voice, text or video. With a broad portfolio of GPS modules, chips, and software solutions together with wireless modules and solutions, u-blox is uniquely positioned to enable OEMs to develop innovative solutions quickly and cost-effectively. Headquartered in Switzerland and with global presence in Europe, Asia and the Americas, u-blox employs 200 people. Founded in 1997, u-blox is listed on the SIX Swiss Exchange. (www.u-blox.com) About LTX-Credence Corporation LTX-Credence is a global provider of focused, cost-optimized ATE solutions designed to enable customers to implement best-in-class test strategies to maximize their profitability. LTX-Credence addresses the broad, divergent test requirements of the wireless, computing, automotive and entertainment market segments, offering a comprehensive portfolio of technologies, the largest installed base in the Asia-Pacific region, and a global network of strategically deployed applications and support resources. Additional information can be found at www.ltxc.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: BPHX - BluePhoenix Solutions Ltd.) LATEST NEWS!! BluePhoenix Announces Executive Management Changes Arik Kilman Appointed CEO,Yaron Tchwella nominated to join the Board of Directors, Gur Shomron Appointed Chairman of Board of Directors HERZLIYA, Israel, Apr 13, 2010 --BluePhoenix Solutions (Nasdaq: BPHX), the leader in value-driven legacy IT modernization solutions, today announced that Arik Kilman was appointed Chief Executive Officer replacing Yaron Tchwella who is leaving the position of Chief Executive Officer for personal reasons. Mr. Tchwella was nominated by the Board of Directors to serve as a Director. If approved by the Company's shareholders at the shareholders meeting which is expected to be held prior to the end of June 2010, Yaron will join the board and will serve as an executive focused on growing the Company's partner network and on strategic customers. Gur Shomron, a member of the Board of Directors was appointed to replace Mr. Kilman as Chairman of the Board. "I return to lead BluePhoenix as CEO at a time when I am increasingly excited about our future," said Mr. Kilman. "The prospects for our solutions continue to grow and we strongly believe that now is the right time for legacy modernization. The market opportunity ahead of us is growing, we own an ever-improving business proposition for our customers and our reputation within the industry is unmatched." About BluePhoenix Solutions BluePhoenix Solutions (NASDAQ: BPHX) is the leading provider of value-driven legacy IT modernization solutions. The BluePhoenix portfolio includes a comprehensive suite of tools and services from global IT asset assessment and impact analysis to automated database and application migration, rehosting, and renewal. Leveraging over 20 years of best-practice domain expertise, BluePhoenix works closely with its customers to ascertain which assets should be migrated, redeveloped, or wrapped for reuse as services or business processes, to protect and increase the value of their business applications and legacy systems with minimized risk and downtime. BluePhoenix provides modernization solutions to companies from diverse industries and vertical markets such as automotive, banking and financial services, insurance, manufacturing, and retail. Among its prestigious customers are: Aflac, Capita Group, CareFirst, Citigroup, Danish Commerce and Companies Agency, Desjardins, Los Angeles County Employees Retirement Association, Rabobank, Rural Servicios Informaticos, SDC Udvikling, TEMENOS, Toyota, and Volvofinans. BluePhoenix has 13 offices in the USA, UK, Denmark, Germany, Italy, The Netherlands, Romania, Russia, Cyprus, Australia, and Israel. ------------------------------------------------------------------------------------------------------------------------------------------------------------ About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. ((Comments on this story may be sent to [email protected])) (c) 2010 M2 COMMUNICATIONS |